When do you repeat a coronary artery calcium (CAC) score?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Repeat Coronary Artery Calcium (CAC) Score

For most patients with an initial CAC score of zero, repeat scanning should be performed in 5 years, while those with CAC scores between 1-400 warrant repeat testing in 3-5 years if results would change management decisions. 1, 2

Standard Rescanning Intervals by Initial CAC Score

CAC = 0 (Zero Calcium)

  • Low-risk patients (<5% 10-year ASCVD risk): Repeat CAC in 5-7 years 2
  • Borderline to intermediate-risk patients (5-19.9% 10-year risk): Repeat in 3-5 years 2
  • General recommendation: Do not repeat sooner than 5 years from initial scan 1, 3
  • Research demonstrates that 62% of patients with initial CAC = 0 remain at zero even after 5 years, and only 2% develop significant progression (>50 units) 3

CAC = 1-99 (Mild Disease)

  • Repeat scoring in 3-5 years if results might change treatment decisions 2
  • This interval applies when progression would support intensification of preventive management 2

CAC = 100-400 (Moderate Disease)

  • Standard patients: Repeat at 3-5 years 2
  • Diabetic patients: Repeat at 3 years 1, 2
  • Patients with LDL-C ≥70 mg/dL: Repeat at 3 years to assess for accelerated progression (>20-25% per year) or increase to CAC >300 2

CAC >400 (Extensive Disease)

  • Repeat CAC generally not required, as these patients are typically symptomatic and already receiving vigorous treatment 1, 2
  • Functional testing may be indicated on an individualized basis rather than repeat calcium scoring 1

Clinical Scenarios Requiring Earlier Rescanning (3-5 Years)

High-Risk Clinical Features

Even with CAC = 0, consider repeat scanning in 3-5 years for patients with: 2

  • Active cigarette smoking (CAC = 0 does not exclude noncalcified plaque risk)
  • Diabetes mellitus
  • Chronic inflammatory conditions (rheumatoid arthritis, psoriasis) where CAC = 0 does not exclude increased thrombotic risk
  • Family history of premature ASCVD, particularly in younger patients
  • Metabolic syndrome (increases progression risk despite initial zero score)

Patients Who Deferred Pharmacotherapy

  • Canadian guidelines specifically recommend repeat scans after CAC = 0 when personal risk factors are present or pharmacotherapy was initially deferred 2
  • This applies particularly when the initial zero score was used to justify withholding statin therapy 2

High-Risk Patients (≥20% 10-Year ASCVD Risk)

  • Warrant repeat scanning at 3 years regardless of initial score 2

When NOT to Repeat CAC

Contraindications to Rescanning

  • Patients already on optimal medical therapy with high CAC scores (>400) 1, 2
  • Symptomatic patients who require functional testing or invasive evaluation rather than repeat calcium scoring 1
  • Any interval <3 years from initial scan, as progression data is unreliable over shorter periods 1, 3

Canadian Guideline Exception

  • Canadian guidelines do not recommend repeat scans after CAC = 0 unless personal risk factors are present or pharmacotherapy was deferred 1
  • This represents a more conservative approach compared to ACC/AHA recommendations 1

Critical Caveats and Pitfalls

Do Not Down-Classify Risk Despite CAC = 0 in:

  • Persistent smokers (may harbor noncalcified plaque) 2
  • Diabetic patients (increased thrombotic risk independent of calcium) 2
  • Patients with chronic inflammatory conditions (increased risk despite zero calcium) 2
  • Strong family history of premature ASCVD (genetic risk not reflected in calcium score) 2

Statin Therapy Effects on Serial Scanning

  • Prolonged statin therapy may have procalcific effects on coronary atheromas and can increase CAC 2
  • Interpretation of serial CAC scores should account for statin use, as progression may reflect plaque stabilization rather than worsening disease 2
  • Research shows statin-treated patients demonstrate 15% annual increase versus 39% in untreated patients, representing a 61% reduction in progression rate 4

Cost and Insurance Considerations

  • Repeat CAC testing is generally considered inappropriate by some guidelines and may not be covered by insurance 2
  • Clinical utility must justify the expense, as costs are often borne entirely by the patient 5
  • Discussion regarding implications of repeat CAC results should occur before testing is recommended 5

Algorithmic Approach to Repeat CAC Timing

Step 1: Assess Initial CAC Score

  • CAC = 0 → Proceed to Step 2
  • CAC 1-99 → 3-5 years if results would change management
  • CAC 100-400 → 3-5 years (3 years if diabetic or LDL-C ≥70)
  • CAC >400 → Generally do not repeat

Step 2: For CAC = 0, Assess Risk Factors

  • Low risk (<5% 10-year ASCVD) without risk enhancers → 5-7 years 2
  • Borderline/intermediate risk (5-19.9%) → 3-5 years 2
  • High risk (≥20%) → 3 years 2
  • Presence of diabetes, smoking, inflammatory conditions, or family history → 3-5 years 2

Step 3: Consider Whether Results Would Change Management

  • If patient already on optimal therapy → Do not repeat 2
  • If progression would support treatment intensification → Proceed with repeat at appropriate interval 2
  • If patient deferred pharmacotherapy based on CAC = 0 → Repeat in 3-5 years 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Conditions Warranting Earlier Repeat Calcium Scoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rates of progression of coronary calcium by electron beam tomography.

The American journal of cardiology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.